Bueter, Marco

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Pfister, D., Núñez, N. G., Pinyol, R., Govaere, O., Pinter, M., Szydlowska, M., Gupta, R., Qiu, M., Deczkowska, A., Weiner, A., et al. (2021) · Nature

Cancer Immunotherapy and BiomarkersHepatocellular Carcinoma Treatment and Prognosis

Cited by 1,294

Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial

Peterli, R., Wölnerhanssen, B. K., Peters, T., Vetter, D., Kröll, D., Borbély, Y., Schultes, B., Beglinger, C., Drewe, J., Schiesser, M., et al. (2018) · JAMA

Bariatric Surgery and OutcomesMinimally Invasive Surgical Techniques

Cited by 1,267

IFSO worldwide survey 2020–2021: current trends for bariatric and metabolic procedures

Angrisani, L., Santonicola, A., Iovino, P., Palma, R., Kow, L., Prager, G., Ramos, A., Shikora, S., the Collaborative Study Group for the IFSO Worldwide Survey, Fiolo, F., et al. (2024) · Obesity Surgery

Bariatric Surgery and OutcomesMinimally Invasive Surgical Techniques

Cited by 289

Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation

le Roux, C. W., Borg, C., Wallis, K., Vincent, R. P., Bueter, M., Goodlad, R., Ghatei, M. A., Patel, A., Bloom, S. R., & Aylwin, S. J. B. (2010) · Annals of Surgery

Bariatric Surgery and OutcomesRegulation of Appetite and Obesity

Cited by 176

Changes in Eating Behaviour and Meal Pattern Following Roux-En-Y Gastric Bypass

Laurenius, A., Larsson, I., Bueter, M., Melanson, K. J., Bosaeus, I., Forslund, H. B., Lönroth, H., Fändriks, L., & Olbers, T. (2012) · International Journal of Obesity

Bariatric Surgery and OutcomesNutrition, Health and Food Behavior

Cited by 174